Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Glide Pharmaceutical Technologies
Glide Pharmaceutical Technologies
Activities:
Drug Delivery
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
IMPACT CKD model reveals the escalating toll of chronic kidney disease
The model projects up to 125 million of the population across eight countries to suffer from chronic kidney disease by 2032
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Isospec Analytics launches biomolecular analysis technology to identify unknown molecules
The novel technology optimises the identification process of unknown molecules compared to mass analysis
Building strong foundations for a resilient and planet-friendly future
Having recently released its inaugural environmental, social and governance (ESG) report, Dr Kevin Robinson caught up with Gigi Bat-Erdene, Global ESG Program Manager at PCI...
ten23 health and Ypsomed collaborate to commercialise the YpsoDose patch injector
The partnership will bring the drug delivery device to the pharmaceutical market quicker, whilst reducing development risks
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Research & Development
Glide Technologies collaborates with Cilian to develop flu vaccine
Will develop a solid dose formulation of CiFlu recombinant influenza vaccine
Research & Development
Glide skin delivery and human factor studies highlight ease-of-use of solid dose injection system
Company plans to evaluate octreotide product in a clinical bioequivalence study in Q4 2015
Manufacturing
AMRI to manufacture clinical trial product for Glide Technologies
Will install the clinical production line developed by Glide into its newly acquired GMP facility in Glasgow
Drug Delivery
Glide Pharma to work with Nypro Healthcare for scale-up of delivery device
Glide SDI injects drugs and vaccines in a solid dosage form without requiring a needle
Manufacturing
Glide Pharma to work with Nypro Healthcare for scale up of solid dose delivery device
The Glide SDI injects drugs and vaccines in a solid dosage form without the need for a needle
Drug Delivery
Glide Pharma raises £14m for scale up of manufacturing processes
For proprietary Glide-SDI solid dose injector system
Drug Delivery
Glide Pharma wins
Existing investors Hygea VCT and Oxford Technology VCT have made further investment in pharmaceutical firm Glide Pharma as part of a
Subscribe now